ABH Healthcare IPO
Healthcare • ₹34.98 Cr
High risk because:
- 5 material risk factors disclosed in DRHP
- SME listing with thinner post-listing liquidity
- The company has a limited operating and financial history as a corporate entity, having be…
IPOFins risk score from DRHP risk factors, subscription demand & issue structure
Price Band
₹102
Lot Size
1200 shares
Issue Size
₹34.98 Cr
Open
24 Aug 2026
Close
27 Aug 2026
Subscription
1.41×
IPO Schedule
| Issue Open Date | 24 Aug 2026 |
| Issue Close Date | 27 Aug 2026 |
| Allotment Date | 28 Aug 2026 |
| Listing Date | 31 Aug 2026 |
About ABH Healthcare
ABH Healthcare Limited operates a hospital providing tertiary medical care in Ferozepur, Punjab. The company operates the 150-bed Anil Baghi Hospital, which was established in 1985 and acquired by the company in 2022. The hospital provides services across 25 medical specialities, including cardiac sciences, neurology, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, orthopaedics and joint replacement, obstetrics and gynaecology, critical care, dentistry, physiotherapy, dermatology, laboratory investigations and radiology. The hospital is empaneled with over 30 private and public health insurance companies and third-party administrators, as well as various government schemes. It received NABH accreditation in 2021 and NABH Digital Standards accreditation in FY25. The company also uses a patient portal, website, Computerised Physician Order Entry system, and Electronic Health Record platform. As of June 30, 2026, this 150-bed hospital, as of FY26, had 37 doctors and 101 nurses.
Company Details
Founders / Promoters
Dr. Saurabh Baghi
Founded
2021
Registrar
BIGSHARE
Documents
DRHP / RHP Document (PDF)
View official prospectus →
Investment Analysis
ABH Healthcare — IPOFins Verdict
QuantitativeDriven by QIB demand at 8.4x and elevated disclosed risk (7/10), ABH Healthcare listed at a discount of 2.9% to its issue price. SME listings are also thinner and more volatile after listing. The signals look weak — weigh the risks carefully. This is a quantitative flag, not a recommendation.
- The company is led by a management team with experience in healthcare and clinical practice. Promoter and Whole-time Director Dr Kamal Baghi has around four decades of experience in the healthcare sec
- As of June 30, 2026, the company had 37 doctors and 101 nurses. Over 30% of its doctors had been associated with the company for more than five years, while some senior doctors have been associated wi
- The hospital provides services across 25 specialties, including internal medicine and critical care, cardiology, neurosurgery, general surgery, orthopaedics and joint replacement, gastroenterology, ne
- The company derives inpatient revenue from government schemes and PSUs, insurance companies and third-party administrators, as well as self-pay patients. In FY26, these categories accounted for 52.40%
- The company is empaneled with more than 30 private and public health insurance companies and third-party administrators. It is also empaneled under schemes and institutions including ECHS, Railways, F
Score breakdown — what drove this verdict
High risk from DRHP → score -0.8
Institutional subscription → score +1.0
Actual listing outcome → score −0.5
SME IPOs have lower liquidity after listing → score −0.5
Base score: 5.0 · Final score = base + all factor adjustments, capped 1–10. Full methodology →
IPOFins Score is a quantitative signal from subscription demand, disclosed risk, and listing data — not investment advice. Not SEBI-registered.
Listing Performance
Issue Price
₹102
Listing Price
₹99
Listing Gain/Loss
-2.94%
Listing Date
31 Aug 2026
Price Since Listing
Returns are measured against the ₹102 issue price.
Listing
₹99
-2.9%
Current
₹62.7
-38.5%
Want to buy this stock?
Trade ABH Healthcare on the secondary market
FAQ
What is the price band of ABH Healthcare IPO?
The price band is ₹102 per share with a lot size of 1200 shares. Minimum investment: ₹1,22,400.
What does ABH Healthcare do?
ABH Healthcare Limited operates a hospital providing tertiary medical care in Ferozepur, Punjab. The company operates the 150-bed Anil Baghi Hospital, which was established in 1985 and acquired by the company in 2022. The hospital provides services across 25 medical specialities, including cardiac sciences, neurology, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, orthopaedics and joint replacement, obstetrics and gynaecology, critical care, dentistry, physiotherapy, dermatology, laboratory investigations and radiology. The hospital is empaneled with over 30 private and public health insurance companies and third-party administrators, as well as various government schemes. It received NABH accreditation in 2021 and NABH Digital Standards accreditation in FY25. The company also uses a patient portal, website, Computerised Physician Order Entry system, and Electronic Health Record platform. As of June 30, 2026, this 150-bed hospital, as of FY26, had 37 doctors and 101 nurses.
Should I apply for ABH Healthcare IPO?
ABH Healthcare listed at ₹99 (-2.9% discount to the ₹102 issue price) after 1.4x subscription. IPOFins Score 4/10: Driven by QIB demand at 8.4x and elevated disclosed risk (7/10), ABH Healthcare listed at a discount of 2.9% to its issue price. SME listings are also thinner and more volatile after listing. The signals look weak — weigh the risks carefully. This is a quantitative flag, not a recommendation.
Who founded ABH Healthcare?
ABH Healthcare was founded by Dr. Saurabh Baghi in 2021.